A new venture in Singapore aims to tackle two of the biggest challenges faced by biotech and food tech start-ups in South ...

A new analysis of a pigeon-sized Archaeopteryx fossil in the collection of the Field Museum in Chicago is revealing an array ...

Among the most serious problems contributing to K-12 science education’s decline, they noted, were a general degradation of ...

Two small studies published recently in Nature offer early, but important validation that stem cell treatments for Parkinson’s disease are viable. They also are a step toward a future where stem ...

On track to begin rolling submission of Biologics License Application (BLA) for INO-3107 as a potential treatment for recurrent respiratory papillomatosis (RRP) in ...

Tesla rose by 4.07%, and Elon Musk held talks with the Governor of Qatar Central Bank and the Chairman of Qatar Investment Authority. Additionally, data showed that Tesla's Shanghai Gigafactory ...

American Homes 4 Rent delivered a solid 9% total return over the past year, supported by favorable macro fundamentals and ...

Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical-stage biopharmaceutical company pioneering ...

Discover the Viral Pumpkin Seed Tea Ritual Backed by Gut Health Science and Celebrity Buzz—Now Reinvented as GutDrops for Fat ...

On this episode of Fortune’s Leadership Next podcast, cohosts Diane Brady, executive editorial director of the Fortune CEO ...

Good morning ladies and gentlemen, and welcome to the DiaMedica Therapeutics First Quarter 2025 Conference Call. An audio recording of the webcast will be available shortly after the call today on ...

Not designing with manufacturing in mind—even during early development—is a key reason fledgling biopharma companies fail.